Lingxiao Qiu

401 total citations
17 papers, 272 citations indexed

About

Lingxiao Qiu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Lingxiao Qiu has authored 17 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 3 papers in Physiology. Recurrent topics in Lingxiao Qiu's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), RNA modifications and cancer (3 papers) and Epigenetics and DNA Methylation (2 papers). Lingxiao Qiu is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), RNA modifications and cancer (3 papers) and Epigenetics and DNA Methylation (2 papers). Lingxiao Qiu collaborates with scholars based in China, Australia and Italy. Lingxiao Qiu's co-authors include Guojun Zhang, Wenjuan Wu, Hongxia Jia, Yangyang Yuan, Huaqi Wang, Tongwen Sun, Nana Li, Yan Yan, Xiaojuan Zhang and Yanan Xu and has published in prestigious journals such as Frontiers in Immunology, Colloids and Surfaces B Biointerfaces and Oxidative Medicine and Cellular Longevity.

In The Last Decade

Lingxiao Qiu

16 papers receiving 270 citations

Peers

Lingxiao Qiu
Yaqiu Sang United States
Juanjuan Cui China
Takaaki Kamatani Japan
Lihua Hu China
Yiqing Li China
Preecha Ruangvejvorachai Thailand
Katherine J. Kearney United Kingdom
Hong Ma China
Dévy Diallo France
Monica Sharma United States
Yaqiu Sang United States
Lingxiao Qiu
Citations per year, relative to Lingxiao Qiu Lingxiao Qiu (= 1×) peers Yaqiu Sang

Countries citing papers authored by Lingxiao Qiu

Since Specialization
Citations

This map shows the geographic impact of Lingxiao Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingxiao Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingxiao Qiu more than expected).

Fields of papers citing papers by Lingxiao Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingxiao Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingxiao Qiu. The network helps show where Lingxiao Qiu may publish in the future.

Co-authorship network of co-authors of Lingxiao Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingxiao Qiu. A scholar is included among the top collaborators of Lingxiao Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingxiao Qiu. Lingxiao Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wu, Wenjuan, Hongxia Jia, Xinran Ma, et al.. (2024). Inhibition of OGG1 ameliorates pulmonary fibrosis via preventing M2 macrophage polarization and activating PINK1-mediated mitophagy. Molecular Medicine. 30(1). 72–72. 9 indexed citations
2.
Qiu, Lingxiao, Chen Zhao, Xinye Zhang, et al.. (2024). MS4A15 gene expression as a prognostic marker for clinical outcomes in lung adenocarcinoma. Translational Lung Cancer Research. 14(1). 224–238.
3.
Wu, Wenjuan, Xinhui Wu, Lingxiao Qiu, et al.. (2023). Quercetin influences intestinal dysbacteriosis and delays alveolar epithelial cell senescence by regulating PTEN/PI3K/AKT signaling in pulmonary fibrosis. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(7). 4809–4822. 17 indexed citations
4.
Hu, Chunling, Yang Liu, Chen Bai, et al.. (2022). Tanreqing Injection Attenuates Macrophage Activation and the Inflammatory Response via the lncRNA-SNHG1/HMGB1 Axis in Lipopolysaccharide-Induced Acute Lung Injury. Frontiers in Immunology. 13. 820718–820718. 22 indexed citations
5.
Zhang, Yan, Xiaoyu Chen, Ping Li, et al.. (2022). HBO1 induces histone acetylation and is important for non-small cell lung cancer cell growth. International Journal of Biological Sciences. 18(8). 3313–3323. 23 indexed citations
6.
Wu, Wenjuan, et al.. (2022). Contribution of Adiponectin/Carnitine Palmityl Transferase 1A‐Mediated Fatty Acid Metabolism during the Development of Idiopathic Pulmonary Fibrosis. Oxidative Medicine and Cellular Longevity. 2022(1). 5265616–5265616. 12 indexed citations
7.
Song, Heng, Xiaojuan Zhang, Huoyan Liang, et al.. (2022). Metformin attenuated sepsis-associated liver injury and inflammatory response in aged mice. Bioengineered. 13(2). 4598–4609. 36 indexed citations
8.
Li, Fangfang, et al.. (2022). Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma. Frontiers in Endocrinology. 13. 894754–894754. 2 indexed citations
9.
10.
Qiu, Lingxiao, Pan Song, Huaqi Wang, et al.. (2021). Clinical Characteristics and Prognosis of Patients With Pulmonary Mucoepidermoid Carcinoma: A SEER-Based Analysis. Frontiers in Oncology. 11. 601185–601185. 11 indexed citations
11.
Qiu, Lingxiao, Wenjuan Wu, Nana Li, et al.. (2021). A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes. Annals of Translational Medicine. 9(20). 1570–1570. 15 indexed citations
12.
Li, Nana, et al.. (2021). Bioinformatic analysis of differentially expressed genes and pathways in idiopathic pulmonary fibrosis. Annals of Translational Medicine. 9(18). 1459–1459. 16 indexed citations
13.
Wang, Huaqi, Yunfei Wang, Chunya Lu, et al.. (2021). The efficacy of probiotics in patients with severe COVID-19. Annals of Palliative Medicine. 10(12). 12374–12380. 22 indexed citations
14.
Qiu, Lingxiao, et al.. (2021). A novel prognostic signature based on five-immune-related genes for idiopathic pulmonary fibrosis. OA4327–OA4327. 1 indexed citations
15.
Li, Zhaonan, Dechao Jiao, Wenguang Zhang, et al.. (2021). Antibacterial and antihyperplasia polylactic acid/silver nanoparticles nanofiber membrane-coated airway stent for tracheal stenosis. Colloids and Surfaces B Biointerfaces. 206. 111949–111949. 31 indexed citations
16.
17.
Qiu, Lingxiao, et al.. (2019). The efficacy of tranexamic acid for orthognathic surgery: a meta-analysis of randomized controlled trials. International Journal of Oral and Maxillofacial Surgery. 48(10). 1323–1328. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yaqiu Sang Breakdown of academic impact, for papers by Juanjuan Cui Breakdown of academic impact, for papers by Takaaki Kamatani Breakdown of academic impact, for papers by Lihua Hu Breakdown of academic impact, for papers by Yiqing Li Breakdown of academic impact, for papers by Preecha Ruangvejvorachai Breakdown of academic impact, for papers by Katherine J. Kearney Breakdown of academic impact, for papers by Hong Ma Breakdown of academic impact, for papers by Dévy Diallo Breakdown of academic impact, for papers by Monica Sharma
Rankless by CCL
2026